NMD4C Welcomes Two New Staff Members
The NMD4C recently welcomed two new members to the network coordination team! Victoria Larocca, PhD joins us as the new Training and Curriculum Coordinator, and Zainab Adamji joins as the Outcome Measures and Natural History Coordinator.
Victoria Larocca, PhD | Training and Curriculum Coordinator
Victoria is a dedicated knowledge mobilization specialist with a passion for advancing health research and education. She earned her Ph.D. and M.Sc. in Kinesiology and Health Science from York University in 2022 and 2018, respectively, following her Bachelor of Education from Brock University in 2016.
Throughout her academic journey, Victoria has immersed herself in health psychology and clinical research. With her experience and education in health research, Victoria is committed to advancing the education and curriculum for neuromuscular trainees as well as advancing the research conducted at Muscular Dystrophy Canada.
Zainab Adamji | Outcome Measures and Natural History Coordinator
Zainab is a dedicated knowledge mobilization specialist with a passion for translating research into practical applications and influencing policy. She earned her Honours B.Sc. in Biology, specializing in Biotechnology, from the University of Waterloo in 2020, followed by an MSc in Molecular Science from Toronto Metropolitan University in 2022. During her academic studies, Zainab researched lysosome dysfunction and its intricate impacts on organelle cross-talk. Zainab has supported numerous research and advocacy initiatives at Muscular Dystrophy Canada and has further honed her expertise through the MobilizeU knowledge mobilization certification program at York University.
Within her role at the NMD4C, Zainab works to coordinate NMD outcome measures, developing training modules and provide training on validated NMD outcome measures, and selecting patient-reported outcome measures to be captured in post-market surveillance patient registries.
Read next...
NMD4C Receive Excellence in Service Delivery Award and Network Investigators Honored as part of Muscular Dystrophy Canada’s 2024 Dr David Green Awards
We are excited to share that the NMD4C has been awarded the Excellence in Service Delivery Award, one of the annual Dr David Green Awards presented by Muscular Dystrophy Canada.
NMD4C Launch Canadian Neuromuscular Clinical Trial Network
We are thrilled to announce the launch of a Canadian neuromuscular clinical trial network (CTN) as a part of our clinical research work.
Training Session for Physiotherapists and Occupational Therapists on Outcome Measures in Spinal muscular atrophy hosted by Quebec SMA Network
This past March 23, the Quebec SMA Network (Réseau québécois de l’amyotrophie spinale – RQAS) in collaboration with the NMD4C and Muscular Dystrophy Canada (MDC) hosted an interactive training session for French-speaking physiotherapists and occupational therapists on assessment measures and practices for Spinal muscular atrophy (SMA). This training gathered clinicians to train and discuss SMA standardized outcome measures and work through current problems/challenges, to improve how these measures often tied to drug reimbursement are conducted.
MDC Announce Recipients of 2024 Neuromuscular Clinical and Translational Research Grants
Muscular Dystrophy Canada (MDC) recently announced the recipients of its annual Neuromuscular Research Grants competition. Through these grants, MDC is investing $900,000 into clinical and translational research projects.
SMA Outcome Measures Training for Physiotherapists and Occupational Therapists
To support the development and training on validated NMD outcome measures we are pleased to provide opportunities for physiotherapists and occupational therapists to attend training sessions for outcome measures.
Congratulations to the 2024 NMD4C Early Career Awards Recipients
We are excited to announce the recipients of the 2024 NMD4C Early Career Awards! This is the second year of our annual award program, celebrating excellence and contribution to the neuromuscular field from early career investigators across both clinical and basic science streams.